TCM
BIVI icon

Traynor Capital Management’s BioVie BIVI Stock Holding History

Traynor Capital Management’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,800
Closed -$16.8K – 370
2025
Q2 		$16.8K Buy
1,800
+200
+13% +$1.98K ﹤0.01% 257
2025
Q1 		$15.7K Buy
+1,600
New +$25.6K ﹤0.01% 246

Other funds holding BIVI

DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.37B AUM 71.68% 1-Year Est. Return
PWM
Prosperity Wealth Management San Ramon, California $300M AUM 28.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.56B AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Traynor Capital Management's BIVI Position: Q3 2025 in Review

Traynor Capital Management sold out of BioVie (BIVI) in Q3 2025, closing a stake of 1,800 shares — an estimated $16.8K sold.

Traynor Capital Management first reported a position in BIVI in Q1 2025 and held it in 2 quarters. The position peaked at $16.8K in Q2 2025. 32 funds tracked by Wall St. Rank hold BIVI as of Q3 2025.

  • Traynor Capital Management reported no remaining BioVie position as of Q3 2025 after selling out during the quarter.
  • Traynor Capital Management sold 1,800 BioVie shares in Q3 2025, an estimated $16.8K.
  • Traynor Capital Management first reported a position in BioVie in Q1 2025 and held it in 2 quarters.
  • Traynor Capital Management's BioVie position peaked at $16.8K in Q2 2025.
  • 32 funds tracked by Wall St. Rank held BioVie as of Q3 2025.

Based on Traynor Capital Management's 13F filing for Q3 2025, filed 3 Nov 2025.